These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 192908)

  • 21. Comparative sequence analyses of Epstein-Barr virus nuclear antigen-2 and -3B genes of a fresh Epstein-Barr virus-2 isolate.
    Inoue N; Kikuta H; Yanagi K
    Intervirology; 1992; 33(4):180-6. PubMed ID: 1339417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubilisation of Epstein-Barr virus (EBV)-associated nuclear antigen from Raji cells and chromatin by treatment with various molarities of NaCl.
    Brown TD; Rickwood D; MacGillivray AJ; Klein G
    Cancer Lett; 1977 Sep; 3(3-4):151-6. PubMed ID: 198113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.
    Fischer DK; Robert MF; Shedd D; Summers WP; Robinson JE; Wolak J; Stefano JE; Miller G
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):43-7. PubMed ID: 6320171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV) antigenic determinants on subunits of the EBV determined nuclear antigen (EBNA).
    Hentzen D; Lenoir GM; Berthelon MC; Daillie J
    Biochem Biophys Res Commun; 1980 Sep; 96(1):425-32. PubMed ID: 6159888
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
    Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization and quantitation of EBV-associated nuclear antigen (EBNA) in Raji cells.
    Bahr GF; Mikel U; Klein G
    Beitr Pathol; 1975 May; 155(1):72-8. PubMed ID: 168861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines.
    Boguszaková L; Hirsch I; Brichácek B; Vonka V
    J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
    Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of the Epstein-Barr virus nuclear antigen 2 using monoclonal antipeptide antibodies.
    Dillner J; Wendel-Hansen V; Kjellström G; Kallin B; Rosén A
    Int J Cancer; 1988 Nov; 42(5):721-7. PubMed ID: 2846447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.
    Ohno S; Luka J; Lindahl T; Klein G
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1605-9. PubMed ID: 67603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement.
    Liabeuf A; Nelson RA; Kourilsky FM
    Int J Cancer; 1975 Apr; 15(4):533-46. PubMed ID: 166939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early nuclear antigen as DNA-binding protein in cytomegalovirus-infected cells.
    Gergely L; Czeglédy J; Váczi L
    Intervirology; 1980; 13(6):352-6. PubMed ID: 6252117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.
    Grogan EA; Summers WP; Dowling S; Shedd D; Gradoville L; Miller G
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7650-3. PubMed ID: 6324183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos).
    Takimoto T; Sato H; Ogura H
    Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between Epstein-Barr virus-determined complement-fixing antigen and nuclear antigen detected by anticomplement fluorescence.
    Klein G; Vonka V
    J Natl Cancer Inst; 1974 Dec; 53(6):1645-6. PubMed ID: 4373574
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
    Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
    J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.